Podcasts about Receptor

Hey everyone,Fresh out the reactor this week we've got bangers from Transforma, Receptor x Skrimor, TNTKLZ, MEL, Absu_NTQL, Confusion, Saint Rider & more.In Demos, WIPs, and Promos, we're checking out upcoming heaters from Current Value, Magnetude, Skrimor, Mizo & more.It's a bumper episode this week since we missed one last week — get locked in, big love from Ollie! Check out the track list below and let's dive in!Blinded Theory - Pass / Vyugahttps://cygnusmusic.link/knalmayDon't forget you can catch us LIVE recording Stonxcast on Twitch every Friday at 7pm (UK)TRACKLIST AND MORE INFO: www.stonxmusic.co.uk/stonxcast-ep138

Packers eligió a receptor en primera ronda por primera vez desde 2022. ¿Por qué rompieron tradición en el NFL Draft 2025?=============

Featuring an interview with Dr Adam M Brufsky, including the following topics: Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00) Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52) Clinical Investigator Survey Results (10:05) CME information and select publications

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.

Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics: Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00) Comparing safety profiles of CDK4/6 inhibitors (9:49) Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06) Real-world evidence with CDK4/6 inhibitors (27:31) CME information and select publications

Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer

Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer

Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer

Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer

Hey everyone,Fresh out the reactor this week we've got bangers from Blinded Theory, Screamarts X Enta, 2Whales, Aye Rights & more.In Demos, WIPs, and Promos, we're checking out heaters from the likes of XAETIS, Receptor x Skrimor, Hologram, and Hackwaves & Pezutek.No end mix from our host Ollie this week as he's heading down to London for the Blender 2 Year Anniversary, playing a B2B with XAETIS — big love, see you next week!Blinded Theory - Pass / Vyugacygnusmusic.link/knalmayDon't forget you can catch us LIVE recording Stonxcast on Twitch every Friday at 7pm (UK)TRACKLIST AND MORE INFO: www.stonxmusic.co.uk/stonxcast-ep137

Aaron Rodgers habló sobre su salida de Jets, sus planes de offseason y su posible futuro con Pittsburgh. ¿Debe Steelers pensar en un plan B?=============

We present the seventh episode of Eatbrain Radio Season 2, your guide to the dark side of drum and bass! Grimey, dutty and disgusting all the way! Hosted by @5ha5h label// facebook.com/Eatbra1n twitter.com/eatbrain_now instagram.com/eatbrain eatbrain.net Tracklist // 1. Zigi SC – Recoil [Darkshire Sound] 2. Transforma & Gifta – The Way [Phase Records DNB] 3. Hologram – Crossfire [Eatbrain] 4. Forbidden Society – Kiro [Neksus Sound] 5. BAD SYNTAX – Wildfire (Diode Remix) [Abducted LTD] 6. Screamarts & Enta – Hellhound [Eatbrain] 7. Emperor – Death Tax [Overview Music] 8. Notequal – Echoes [Darkshire Sound, Free Download] 9. Receptor & Skrimor – Red Shift [Evolution Chamber] 10. Ed Rush & Optical – Chubrub (Buunshin Remix) [Patreon Dub] 11. Audio – Flip Mode (Prolix Remix) [Blackout Music] 12. Rift – Sun Skin [C4C Limited] 13. CiDiaH – Gate String [Neuroheadz] 14. Blinded Theory – Vyuga [Stonx Music] 15. PRDK – STARWALKIN [Patreon Dub] 16. Ntechnique & Hellkat – Buran [High Resistance] 17. Rieger – Confession [Paperfunk Recordings] 18. AKOV – Fake Blood [Self Release]

Watch Here : https://www.youtube.com/watch?v=1WV3xTmvPD0 Website: https://vigoroussteve.com/ Consultations: https://vigoroussteve.com/consultations/ eBooks: https://vigoroussteve.com/shop/ YouTube Channel: http://www.youtube.com/user/VigorousSteve/ Workout Clips Channel: https://www.youtube.com/channel/UCWi2zZJwmQ6Mqg92FW2JbiA Instagram: https://instagram.com/vigoroussteve/ TikTok: https://www.tiktok.com/@vigoroussteve Reddit: https://www.reddit.com/r/VigorousSteve/ PodBean: https://vigoroussteve.podbean.com/ Spotify: https://open.spotify.com/show/2wR0XWY00qLq9K7tlvJ000 Patreon: https://www.patreon.com/vigoroussteve

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog Last time we reviewed why interpreting your lab may lead you to the wrong diagnosis and treatment.  Today we continue our review of each lab panel and why the reference ranges on your lab results may not be the “Healthy Normal Range” that you should compare your results to. Lab reference ranges are established with a one-size-fits-all mentality, ignoring the numerous variables that influence blood results. Have you ever tried on a “one-size-fits-all “ANYTHING? Those clothes may fit 20% of the population but for the rest of us, the garment doesn't fit our width, weight or height! All one-size-fits-all lab reference ranges are much the same.  For example, the standardized “reference ranges” in the US serve as a one-size-fits-all “ideal range” applied to everyone, despite genetic differences, varying latitudes, and the diverse diets that characterize the American multiethnic population. This presents the first problem with using a single range for all people: variations among individuals based on differing genetic needs.  The second issue is that the ranges on the lab report indicate the minimum levels necessary for survival, not necessarily the healthiest blood levels for most individuals. Another example of one size doesn't fit all is the reference range for women's hormones. A range is displayed for cycling women, but there is no healthy range for menopausal women.  Does the range displayed refer to menopausal women with HRT, or menopausal women without HRT to treat their menopausal symptoms? Is the range based on what is healthy, or what is average? We aren't sure. Labs don't ask patients questions that could help interpret lab values. Therefore, they cannot provide a truly diagnostic reference range for any illness. They only consider gender and age, as reference ranges are solely adjusted for these two factors.  A doctor must interpret individual lab results alongside a patient's medical and surgical history, including established diseases, medications, supplements, hormonal treatments, and past lab values. For instance, laboratory companies should offer reference ranges based on whether a patient is menopausal, a woman is undergoing ERT, a man is receiving testosterone, a patient is on thyroid medication, a person is being treated for diabetes, or the diabetic tests are performed to diagnose diabetes.   Some Reference Ranges are Based on comparing results to Misleading formulas The best example of this issue is the Lipid Panel. Doctors use this panel to determine a person's risk for heart attacks caused by atherosclerosis. Most doctors don't know the formula for determining Total Cholesterol. This test doesn't predict heart disease in most patients, as the formula used to arrive at that number is not indicative of the disease. However, doctors have been advised that when   total cholesterol levels are high, a patient should start taking a statin, a drug that reduces blood cholesterol and sometimes lowers the rate of heart attacks in certain individuals, though it is rarely predictive in 50% of the population. The problem with the lipid panel is twofold: the LDL level indicates future atherosclerosis in only about 50% of the population and is not a specific test for future heart disease risk. Total cholesterol is even less predictive of heart disease because it stems from a flawed formula. Doctors interpret a high Total Cholesterol level as an indication that a patient may be at increased risk for heart disease in the future. When I test patients with elevated Total Cholesterol or high levels of LDL using a Cardiac Calcium Scan to measure plaque, only half of them actually produce plaque, and consequently, are not at risk for atherosclerotic heart disease. I believe that the Total Cholesterol number is derived from an inaccurate formula for determining a person's risk of future heart disease. The Total Cholesterol number is calculated using a flawed equation. The equation is as follows:         LDL + 1/5 Triglycerides+ HDL = Total Cholesterol Total Cholesterol = LDL (bad cholesterol) + 1/5 Triglycerides (high risk factor) + HDL (good cholesterol) Let's examine this formula simply like this:   Bad + Bad + Good does not equal Bad. Due to this incorrect formula, thousands, if not millions, of patients have been prescribed statin drugs for a lifetime without justification!  Statins carry risks. The list of side effects is extensive and includes muscle deterioration and statin-associated dementia. Unfortunately, most people who experience statin side effects are women. Women tend to have higher HDL levels than men. Additionally, they typically do not have atherosclerotic plaque until menopause and usually do not develop it after menopause if they undergo estrogen replacement therapy! This gender issue is just one of the problems with laboratory reference ranges that are not adjusted for sex. The total cholesterol values were developed solely from the blood levels of men, who typically have lower HDL levels. Women were excluded from the tests conducted to create this blood panel. For women, I dispel the myth that high total cholesterol predicts heart disease by recommending a Cardiac Calcium Scan to check for plaque. If a woman has no plaque by the age of 50 and is taking estrogen, she is unlikely to develop plaque in the future.  I still test them every 2-3 years to ensure that no metabolic changes have altered their risk, but I don't put much faith in the unreliable cholesterol blood panel. There is another blood test that has deceptive reference ranges: IGF-1 How about the GH-IGF-1 test, the test for Growth Hormone?  IGF-1 is a metabolite of GH that we can measure to determine how much the patient produces.  This hormone aids in healing and replenishing aging cells in patients after their growth is complete.  The healthy normal range with which I was trained, (150-350 MIU), has been changed to an age-adjusted normal that compares a person to others in her age category who had their blood drawn the previous year.  What is wrong with this? Growth hormone (GH) decreases with age and contributes to the declining health people experience as they grow older. Similarly, IGF-1 diminishes with age and illness, which means that the “reference range” essentially reflects that you are “average for the sick individuals who visit Quest to have their IGF-1 levels checked. ” IGF-1 levels can be enhanced through weight loss, testosterone replacement, and an increase in muscle mass. The current reference range does not indicate health or illness; it merely shows whether you fall within the average for your age group. This non-scientific method of determining “health” is widespread in contemporary medicine. By comparing aging individuals to others within the same age group, for hormones that decline with age, based on samples from sick patients who visit a specific lab in the past year, these labs label patients as “healthy” even when they are as ill as other individuals their age who go to that lab! This practice constitutes age discrimination! Regarding hormones, the levels we maintained during our fertile and youthful years correspond to the blood levels indicative of health in all individuals ages. For example: People who check their IGF-1 (Growth Hormone) levels and see a low “52 ng/ml” might feel satisfied that they are within the standard range (50-280 ng/ml). However, they may not realize that this range applies to older, unhealthy individuals, not to healthy young ones (150-350 ng/ml).  This is just one example of the issues that arise when non-medical individuals, who do not monitor these tests regularly, draw conclusions from the numbers.   Some illnesses require more than one blood test for diagnosis If you consider only one of the three tests for diabetes or prediabetes (Fasting Blood Sugar, HbA1c, and Insulin), you cannot self-diagnose as diabetic, prediabetic, insulin resistance or healthy.  Diabetes is a disease that has coincided with the rising number of obese individuals.  Both conditions affect nearly 50% of the American population. Blood tests cannot be interpreted accurately unless a patient has fasted for 12 hours; all three tests should be evaluated. When diagnosing diabetes and insulin resistance, we perform three tests to assess whether a patient has insulin resistance, prediabetes, or diabetes. These tests guide our diagnosis and inform the treatment we provide based on their results. Fasting insulin is a highly misleading test. Over 15 years ago, a significant study was conducted that was believed to change the reference ranges for fasting insulin.  The new range set for normal fasting insulin was less than 10 mIU/ml. By publishing the reference range less than 18 mIU/ml, they miss diagnosing many patients with insulin resistance HBA1C is a test that gives a value of average blood sugar over three months. The results are often used alone to determine prediabetes and diabetes; however, considering all three aspects makes the diagnosis and treatment plan more specific for the patient. FBS (fasting blood sugar) is the third diabetes test. It is generally used as a screening test that prompts the ordering of the other two blood tests; however, some patients exhibit symptoms of diabetes and insulin resistance without having elevated fasting insulin levels. Many medications can raise diabetic test values, causing a patient to seem diabetic when they are actually experiencing a side effect of the drug.  One such medication is Atorvastatin.  The solution is not treating diabetes but rather adjusting the medication.  Hormone tests are especially challenging to interpret, Especially when testing free Testosterone in women Here are the problems with the free Testosterone test itself: Women have extremely low levels of free testosterone and testosterone compared to men. I have been informed by Quest that women's free testosterone levels are not reliable with current methods because they are not always reproducible when a test is conducted twice on the same day. This leads me to believe that hormone levels do not always reflect the actual blood levels of free testosterone and estradiol. The levels of testosterone in women are based on menopausal levels of T. Women have long been thought to not produce testosterone, so the “normal” levels are quite low, and 0 used to be considered normal- until one day I managed to persuade a medical director at Quest to increase it to 0.2! Women's testosterone is influenced by their production of E2 and E1, which inactivate free T. Women vary in how their cells respond to testosterone and estradiol. Receptor sites and their genetic acceptance of hormones can mean that the same blood level of testosterone in both sexes does not produce the same effects in all patients. Some women (and men) are resistant to E2 and T, or to one of the two. This indicates that the hormone-free T level may be optimal for one woman while being ineffective in alleviating any low T symptoms for another. The latter individual is T resistant, and we currently have no means outside of research labs to determine which women are sensitive and which are resistant. This requires that doctors and NPs look beyond typical reference ranges to effectively manage E2 and T replacement for women. Lastly some labs use the total testosterone level through a formula determine the free T. This carries inherent risks of reporting the wrong active level of testosterone. Total and free testosterone blood levels for men, are derived from results of older men, rather than from the blood levels that indicate health and the levels at which men experience no symptoms. This leads men to believe they are normal, even though they are symptomatic, and they can't get treatment. There is no time to discuss the reference ranges for LH, FSH, Estradiol, and Estrone; these topics will be addressed in a future blog. I hope I have encouraged you to review your blood work with your doctor or Nurse Practitioner, and not to act as your own doctor by interpreting your blood tests.

Welcome to the Mind Muscle Connection Podcast!In this episode, I'm excited to welcome back coach and bioengineeringgraduate Calvin Scheller to deep dive into the science of GLP-1, appetiteregulation, and what really happens when using popular medications likeOzempic and Wegovy.Calvin brings his deep academic background and real-world coachingexperience to explore the mechanisms behind GLP-1, the truth behindmuscle loss while using these meds, and how to use them responsiblywithout compromising long-term health.If you've been curious about GLP-1 or are coaching clients who are, thisepisode is packed with science, strategy, and nuance you won't want to miss.Let's talk about:00:45 Introduction3:22 Training Split & Recovery Strategies10:25 Nutrition13:11 What is GLP-125:46 Types of GLP-126:46 Muscle Loss & GLP-129:21 Preserving Muscle during medication43:24 Gut Health53:17 GLP-1 Benefits58:59 Where to find Calvin SchellerCalvin Scheller's Instagram: https://www.instagram.com/calvin_scheller/Follow me on Instagram for more information and education:  @jeffhoehn_FREE 30 Min Strategy Call: HEREBody Recomp Checklist 2.0 HERENutrition Periodization Masterclass: HEREHow You Can Work With Me?: HERECoaching application: HEREBody Recomp Checklist 2.0: https://chipper-producer-6244.kit.com/26b5c9f94a

How do the eligibility criteria for the monarchE and NATALEE clinical trials compare? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu

Hey everyone,This week, we've got fresh heaters from Manta, Xylym, Nemean, and Xaetis. Plus, we're diving into some epicDemos, WIPs, and Promos featuring Mythic Image, DIODE, Transforma & Paperclip, and the collab from Receptor x Skrimor.Ollie's back to guide you through this week's heavy selection.JIROBASS - Feral Seekers / The Blackwallcygnusmusic.link/w5plrmqDon't forget you can catch us LIVE recording Stonxcast on Twitch every Friday at 7pm (UK)TRACKLIST AND MORE INFO: www.stonxmusic.co.uk/stonxcast-ep134

The rise and rise of Androgen Receptor Pathway (or Signalling) Inhibitors has changed the world of metastatic prostate cancer forever. What was once a cancer with a finite number of treatment options has flourished into a chasm of therapies, many more effective and less toxic than their therapeutic grandparents.Studies discussed in the episode:ARCHESENZAMETFor more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

1. Karacha: No More 2. Ozma ft. Tasha Baxter: Rise Up 3. Kach: Mom Alcoholic (Kvostax rmx) 4. Defatted: Grayness 5. Defatted: Dawn 6. Defatted: Stepper 7. Defatted: Sun ft. DMPR 8. Magnetude: Broken 9. Receptor ft. K.I.R.A.: Lullaby 10. Prolix ft. Ethan Cronin: In Your Head 11. Dyslexia: Validol 12. DMPR: Gloom & Horror 13. Saint Robbers & VDS: Dark Princess 14. DMPR & Gysnoize: The Invaders 15. Shadow Sect & Hallucinator: Goin' On

A study suggests GLP-1 receptor agonists may reduce hematologic cancer risk in type 2 diabetes patients by 54% compared to insulin. Two individuals have achieved functional HIV cures through stem cell transplants, offering insights into cure strategies. Additionally, women with dense breasts face double the risk of breast cancer and reduced mammogram accuracy, supporting FDA regulations for breast density notifications and additional screening methods.

We have a very important program in store for you this Saturday as The Word on Medicine brings you an information-packed program on the recent explosion of weight loss medications - the so called GLP-1 receptor agonists. Our panel of experts includes Drs. Lisa Morselli, Tammy Kindel, Kate Glasenapp, and Aimee Welsh and in the last segment, one of Dr. Kindel's patients will join for the all-important patient perspective. There is so much information (and misinformation) on this class of medications - - you will not want to miss this program.

Seahawks favorito para firmar a Cooper Kupp, Giants entrevista a Joe Flacco y Russell Wilson; y más noticias de agencia libre NFL 2025.=============

A paralyzed man is able to move a robotic arm using only his thoughts with the help of AI and how the brain cannabinoid receptor is linked to stress. Plus, on This Day in History, we take a look at the Gold Standard Act. Paralyzed Man Moved a Robotic Arm Using Only His Thoughts Thanks to AI. It Kept Working for Months | ZME Science Brain Receptors For Cannabis Could Be Why Some People Are More Resilient : ScienceAlert Brain Cannabinoid Receptor Linked With Stress Resilience in Mice Astocyte endocannabinoid receptor and BBB linked with stress resilience | GEN Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood–brain barrier alterations | Nature Neuroscience What Is the Gold Standard? History and Collapse | Investopedia Contact the show - coolstuffcommute@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast! This week, Drs. Mike and John Fralick discuss two recent papers examining the effect of glucagon-like peptide-1 receptor agonists (GLP1's) on patients living with Parkinson's disease. Two papers, here we go!Trial of Lixisenatide in Early Parkinson's Disease (0:00 – 10:24).Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease (10:25 – 17:40).And for the Good Stuff:Port Blandford artist creates portraits from Scotch tape (17:41 – 18:33).Rheumatology for the Royal College podcast (18:34 – 19:42).This episode is sponsored by Northern Ontario Resident Streamlined Training and Reimbursement Program (NORSTAR). Check out details here!Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract  

The kind of pairing we cherish at Delayed—Enrica Falqui and Claudio PRC, two esteemed artists from their shared homeland of Sardinia, joining forces on Swiss label Adam's Bite. Lucid Dreams EP is the refined result of their collaboration. Available in digital and vinyl formats via Bandcamp from February 28th. Receptor opens the B-side with a hypnotic, cinematic character, driven by a dynamic bass groove. It's a love story between minimal, house, and techno, crafted with a distinct sense of identity. Balanced tension runs throughout, with stripped-down drums underpinning the track's deep, tenacious energy. You can hear both of their personalities woven into the sound with understated heat. From the very first bars, it brings you close and doesn't let go. @claudioprc www.instagram.com/claudioprc/ @enricafalqui www.instagram.com/enricafalqui/ @adamsbite www.instagram.com/adamsbite/ Write up by @danpeplow Follow us on social media: @itsdelayed linktr.ee/delayed www.delayed.nyc www.facebook.com/itsdelayed www.instagram.com/_____delayed www.youtube.com/@_____delayed Contact us: info@delayed.nyc

Dr. Vikram Karnik talks with Dr. Lorraine V. Kalia about the potential role of GLP-1 receptor agonists in neurodegenerative diseases, the current state of research, preclinical evidence, and future directions for GLP-1 agonists. Read the related article in The Lancet. Disclosures can be found at Neurology.org.  

In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract 

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Kevin Kalinsky, a leading breast medical oncologist and director of the breast cancer program at the Winship Cancer Institute of Emory University. Join us as we dive deep into the complexities of hormone receptor-positive breast cancer treatment. We discuss the latest advancements in treatment algorithms, including the use of OncotypeDX in premenopausal versus postmenopausal women, the role of ovarian function suppression, and the implications of new approvals like Inavolisib and CDK4-6 inhibitors. Key topics covered in this episode: •⁠  ⁠The significance of recurrence scores in dictating adjuvant chemotherapy •⁠  ⁠The ongoing OFSET trial and its potential impact on treatment decisions •⁠  ⁠Insights into the use of genomic assays like MammaPrint and RS-Clin •⁠  ⁠The evolving landscape of treatment options for locally advanced and metastatic breast cancer •⁠  ⁠The latest on PARP inhibitors, T-DXd, and other novel therapies Whether you're a medical professional or someone interested in the latest in oncology, this episode is packed with valuable insights and clinical pearls. Don't forget to subscribe for more discussions on cancer treatment, FDA approvals, and conference highlights! YouTube: https://youtu.be/_icBN3J3Bc0 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers #OncologyBrothers #HR+ #breastcancer   #HormoneReceptorPositiveCancer #oncbrothers  #Podcast

کیس تغییر سطح هوشیاری: آنسفالیت خودایمنی ضد گیرنده‌های NMDA Anti NMDA receptor encephalitis

En la quedada de este mes, en el turno de las presentaciones Jaime Franco nos habla de un transmisor/receptor bluetooth Ugreen para dotar de bluetooth a un dispositivo que no lo tenga. Posteriormente, Juan Núñez hace lo propio con una mesa de mezclas Alto TrueMix. Comentar que si se usa cualquier transmisor bluetooth como el presentado en la quedada, por ejemplo, para escuchar con unos auriculares bluetooth el audio de un dispositivo que no tiene esta forma de transmisión inalámbrica, como es el caso del Milestone 312, se puede escuchar su sonido pero no se puede gestionar la reproducción desde los auriculares. Es decir, desde estos no se puede reproducir, pausar, avanzar, retroceder, ni tan si quiera se puede graduar el volumen. Todo eso se tiene que seguir haciendo desde el Milestone. En el turno de las preguntas se responde a una duda de cómo compartir la pantalla en una llamada de Skype en Mac. También se responde a cómo hacer que en Zoom se pueda participar sin problemas desde unos auriculares, pues en ocasiones el micrófono va bien, VoiceOver se escucha también por los auriculares, pero el audio se escucha por los altavoces del Mac. Finalmente, se plantea un problema a la hora de hacer la copia de seguridad en iCloud y de cómo saber cuánto ocupará la siguiente copia. En los temas, Jaime Franco habla de la aplicación para iOS NO Espam, lo cual inicia un debate comparativo con otras apps similares como Pepeescudo y Truecaller, mencionando incluso plataformas como la Lista Robinson y la reciente creada Lista STOP Publicidad. Con respecto a la aplicación NO ESpam, en la quedada Jaime Franco comenta que no le parece accesible el apartado para consultar los números de la base de datos, pero tras probarlo más a fondo, se ha dado cuenta de que sí que es accesible. Si pegamos un número de teléfono en ese cuadro de edición y no aparece nada en la pantalla, es debido a que ese número no se encuentra en la base de datos. Pero si vamos escribiendo ese mismo número dígito a dígito, a partir de introducir el cuarto, en la parte inferior van apareciendo posibles coincidencias, las cuales van disminuyendo a medida que introducimos más dígitos. Además, las coincidencias aparecen filtradas en diversas categorías. El proceso es totalmente accesible con VoiceOver. Enlaces de interés: Receptor y transmisor UGREEN Bluetooth 5.4 con USB en Amazon.   Mesa de mezclas Alto TrueMix 600 en Amazon.   Aplicación NO ESpam en App Store.   Aplicación Pepeescudo en app store.   Aplicación Truecaller en app store.   Web de la Lista anti espam STOP Publicidad.   Web de la Lista anti espam Robinson.  

Metastatic Hormone Receptor-Positive Breast Cancer truly represents the frontier of Medical Oncology, with life expectancy creeping up to and beyond five years. This week, we discuss Monaleesa-2 (Ribociclib), Paloma-2 (Palbociclib) and, of course, highlight the importance of Monarch-3 (Abemaciclib). The great CDK debate continues, and while the phase three trials have a clear winner, it's important to discuss the benefits and cons of each.Studies discussed in the episode:MONALEESA-2PALOMA-2MONARCH-3 (Mention)For more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do. Hosted on Acast. See acast.com/privacy for more information.

Davante Adams quiere jugar en la costa oesta, Commanders busca nuevo corredor y más noticias rumbo a la agencia libre NFL 2025.=============

- Updates from the 47th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors - What's New in the Treatment of ER, PR & HER2 Positive Breast Cancer - Updates from SABCS on Hormone & Targeted Therapy - Chemotherapy Updates from SABCS - Investigational New Drugs in Clinical Trials Reported at SABCS: What's New in Preventing & Managing Treatment Side Effects, Including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer - Key Questions to Ask Your Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts Please note the time for this workshop is 1-2 p.m. ET.

- Updates from the 47th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors - What's New in the Treatment of ER, PR & HER2 Positive Breast Cancer - Updates from SABCS on Hormone & Targeted Therapy - Chemotherapy Updates from SABCS - Investigational New Drugs in Clinical Trials Reported at SABCS: What's New in Preventing & Managing Treatment Side Effects, Including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer - Key Questions to Ask Your Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts Please note the time for this workshop is 1-2 p.m. ET.

A new phase 3 trial demonstrated that adding nivolumab to adjuvant chemotherapy significantly improves outcomes for patients with ER-positive HER2-negative breast cancers. Heavy lifetime cannabis use was associated with reduced brain activity in areas responsible for working memory, suggesting potential long-term cognitive impacts. A study found that EMS clinicians wearing ballistic vests experienced higher rates of workplace violence and increased patient refusal of treatment, particularly among racial and ethnic minority patients.

Discutimos la agencia libre de Tee Higgins, Chris Godwin y Cooper Kupp. También analizamos el Super Bowl 59 con Mike Guerrero.=============

Гостевой live-микс для стрима NEUROBUNKER с Drop Dealerz, voiceless версия. Здесь некоторые мои фавориты за последнее время создают настоящий роллердром, покачивая разными оттенками стиля, переплетая funk и tech, jump up и neuro...Добро пожаловать в музыкальный трип.. GVOZD vibez: 1.Malstrom - ReFunk 2.Unglued x Molecular - Underground Supply 3.wintour - Sahra 4.Alibi, Yatuza- Foundation 5.Objectiv, Illament - OG Call 6.Dkn - Spirits 7.Ogstan - Ghost Story 8.Enei & EN:VY - Drilla 9.Dubdron - Off The Hook 10.Petroll- Kraken 11.T>I, Trex - Mercy Mercy 12.Ńemy - Shoebill Stork 13.Misanthrop- Escape 14.Nais - Double Savage 15.Futurebound, BMotion - Slap Suey (TANTRON Remix) 16.ShockOne - Organism Algorithm (Bensley Remix) 17.Irontype & Frosta - Your Eyes 18.Receptor, Yush, Soham Pathak - Ambabai 19.Skrimor - Black Strings 20.First Person - Thoughts & Emotions 21.TRCD - Break Point 22.Stonx & Sindicate - Gyra 23.Surge - Kamikaze 24.Irontype - Show Me 25.Nebulate - Voodoo 26.Apashe - Lost In Mumbai (feat. Geoffroy) (Synergy Remix) 27.Bad Ace - Reign 28.TNTKLZ - Take The Drop 29.Hot and Nebula - Hornet 30.Mean Teeth - 3 Minutes (Metanoia Remix) 31.Theezer ft. Moody Djins - Control 32.Punchman - Discoteka 33.Morebeat - Paranoids 34.Jack Mirror, Kove - Placebo (Fade Black Remix) 35.Teddy Killerz - NRG (feat. Inja) 36.Glitch City - Fight Like A Bear 37.TESSERACTS - Two Turntables and The Mic 38.Agro - The Sludge 39.Turno & Basslayerz - Pon Di Bill 40.Jabba, Lavance - Too Much 41.Jakes, T>I - Kamikaze 42.Jakes, D*Minds - The Rilla 43.KL - Closer 44.Simple Souls - Like This! 45.Jam Thieves - Exodus 46.Grinder - Last Water 47.GLXY - Rotor 48.Former - GRONINGEN 49.Bonnot - Koomale

Welcome to a monumental celebration in the world of Drum and Bass with The Stress Factor Podcast episode 320, marking a remarkable 15-year journey since its inception on January 1, 2010. This special episode is a thrilling 60 track studio mix by the renowned DJ B-12, designed to take listeners on an exhilarating auditory adventure. Spanning an impressive hour and 43 minutes, the mix showcases the finest in current upfront, liquid, and electro Drum and Bass, featuring euphoric vocals and stunning melodies that will resonate with both long time fans and newcomers alike. The energy is palpable, and the carefully curated selection of tracks promises to elevate your spirits and keep you moving, making it a perfect soundtrack for any occasion. As a heartfelt thank you to the loyal listeners who have supported The Stress Factor Podcast over the years, this episode is a testament to the community that has grown around it. Special acknowledgments go out to DJ Scottie B and Ste-J, who have been integral to the show since its early days, as well as DJ Tribo and R1 for their invaluable contributions. The episode features minimal talking, allowing the music to take center stage, but it does include a special voice message from the podcast's number one VIP listener, Axel The X Engler, adding a personal touch to this celebratory mix. With plans for a highly anticipated best of mix in February, the excitement continues as The Stress Factor Podcast looks forward to another 15 years of delivering the best in Drum and Bass. Big ups to all who have been part of this incredible journey! This episode contains tracks and remixes from the following artists and on the following labels Makoto, Lauren Archer, Liquicity Records, Nkz, Lizplay Records, Nicky Romero, Vikkstar, Alpharock, Oaks, Rameses B, Protocol Recordings, Genemo, YUNA, Saralia, Munix Records, Freaks Geeks, Flowidus, Gia Santho, Elevate Records, AL SO, Plasmator, Manifest, Andromedik, Lauren L'aimant, Akos Gyorfy, Kelle, Celsius Recordings, Friction, Circadian, Fallen State, Mathematica Records, Kleu, LoveThatBass, Receptor, Paperclip, Paperfunk Recordings, Voicians, Gentlemens Club, Lee Mvtthews, DnB Allstars, Marble Elephant, Monika, Spearhead Records, Cyazon, Gracie Van Brunt, Bassrush Records, K2T, DA TU, Offworld Recordings, Technimatic, Zara Kershaw, Keeno, Polaris, Keeno Music, Koven, AEON MODE, Monstercat, Modest Intentions, Formulus, Park Shadow, Straight Up Breakbeat, Rene Lavice, Felix Samuel, DeVice, Bloque, Blean, Interstellar Audio, S.P.Y, ALIBI, flowanastasia, Shogun Audio, Lexed, MAD1AD, Etherwood, UKF, InMost, Fae Vie, Telomic, DuoScience, Rezilient, Dux n Bass, EPITOME, LMX, Kubiks, Pyxis, Alpha Rhythm, Goldfat Records, Hybrid Minds, Lyvia, Melic, DistroKid, Close Inside, Dihanie, Ninkid, Perfect Pitch, Solar Vision, You Love Dance, Sam M, Ridmic, Jolliffe, Sydney Bryce, DrumAndBassArena, Lee Mvtthews, Kate McGill, DIMOD, BazAan, T And Sugah, Amber Jay, Feint, Maduk, Tengu, YosH, Artificial Intelligence, Genetics, Amber Jay, Holy Polly, NMA, Frameshift, Twintone, DNBB Digital, Wardown, Blu Mar Ten Music, Future Shock, Impact Music, Liquefaction, LW Recordings. Tracklist 01. Makoto Ft. Lauren Archer - Invincible [Liquicity Records] 02. Nkz - Bye Bye Darling [Lizplay Records] 03. Nicky Romero x Vikkstar x Alpharock x Oaks - Where Do I Go (Rameses B Extended Remix) [Protocol Recordings] 04. Genemo, YUNA and Saralia - Let Go (Goodbye) [Munix Records] 05. Freaks and Geeks, Flowidus and Gia Santho - Out My Head [Elevate Records] 06. ALSO and Plasmator - Open Your Eyes [Manifest] 07. Andromedik - Air (ft. Lauren L'aimant) [Andromedik] 08. Akos Gyorfy and Kelle - Bastard [Celsius Recordings] 09. Friction - Remember (Circadian Remix) [Elevate Records] 10. Fallen State - What You've Done [Mathematica Records] 11. Kleu - Fading Away (Dub Mix) [LoveThatBass] 12. Receptor and Paperclip - Long Story [Paperfunk Recordings] 13. Voicians - Back In Time [Liquicity Records 14. Receptor - Maybe You Could [Paperfunk Recordings] 15. Gentlemens Club and Lee Mvtthews - Frequency [DnB Allstars] 16. Marble Elephant - Melancholia [Celsius Recordings] 17. Fallen State - Open Mind [Mathematica Records] 18. Monika - Joanna [Spearhead Records] 19. Cyazon and Gracie Van Brunt - My Way Out [Bassrush Records] 20. K2T & DA TU - Unwavering Spirit [Offworld Recordings] 21. Technimatic - Only Dreamers (ft. Zara Kershaw) [Technimatic Music] 22. Keeno - Lights On (Polaris Remix) [Keeno Music] 23. Koven and AEON MODE - Polarised [Monstercat] 24. Modest Intentions and Formulus - Magnetize [Liquicity Records] 25. Park Shadow - Breach [Straight Up Breakbeat] 26. Andromedik - Time [Liquicity Records] 27. Rene Lavice ft. Felix Samuel - Count On You (Extended Mix) [DeVice] 28. Bloque and Blean - The Descent [Interstellar Audio] 29. S.P.Y x ALIBI x flowanastasia - This Is Goodbye [Shogun Audio] 30. Lexed, MAD1AD - It's Not Over [Manifest] 31. Etherwood - Sinking Sand [UKF] 32. Keeno x InMost x Fae Vie - To Feel OK Again (Telomic Remix) [Keeno Music] 33. DuoScience and Rezilient - Tread Lightly [Celsius Recordings] 34. Dux n Bass - Shootingstars [EPITOME] 35. Andromedik - Nothing Like You [Liquicity Records] 36. LMX and Kubiks - See Through [Liquicity Records] 37. Pyxis and Alpha Rhythm - Wanna Say Goodbye [Goldfat Records] 38. Hybrid Minds and Lyvia - Tear Drops [UKF] 39. Melic - Again [DistroKid] 40. Close Inside - Hybrolife [Dihanie] 41. Ninkid, Perfect Pitch and Solar Vision – The Power of Love [You Love Dance] 42. Marble Elephant - Carbon [Celsius Recordings] 43. Sam M - Close To The Edge [Ridmic] 44. Jolliffe and Sydney Bryce - Everything I Know [DrumAndBassArena] 45. Pyxis and Alpha Rhythm - Hummingberg [Goldfat Records] 46. Lee Mvtthews and Kate McGill - Take Me Anywhere [Elevate Records] 47. DIMOD and BazAan - Call Me [Lizplay Records] 48. T and Sugah - Euphoria (ft. Amber Jay) [Liquicity Records] 49. Scatterbrain and HumaNature - Second Thoughts (Subliminal Remix) [Fokuz Recordings] 50. Feint - Divided Sky [Liquicity Records] 51. Maduk - Stay Like This (Telomic Remix) [Liquicity Records] 52. Tengu x Emma Cannon - Coming Back To Me [YosH] 53. Artificial Intelligence and Makoto - Cold Expanse [Liquicity Records] 54. Genetics and Amber Jay - Escape [Ridmic] 55. Holy Polly - Breathe In [NMA] 56. Frameshift and Twintone - For Want Of You [DNBB Digital] 57. Wardown - And They Fell [Blu Mar Ten Music] 58. Future Shock - Alone Again [Impact Music] 59. Liquefaction - Tell Me [LW Recordings] 60. Wardown - No New Messages [Blu Mar Ten Music]

En entrevista para MVS Noticias con Manuel López San Martín, Ezra Shabot, colaborador de MVS Noticias, habló sobre los migrantes expulsados por Trump, un serio problema para los países receptores. "Estamos ante un fenómeno de los migrantes, queda claro que estamos en una situación de que si Trump no se contiene va a generar un problema social de gran magnitud", afirmó Shabot. Explicó que los países de América Latina, a diferencia de Estados Unidos, no están estructurados para recibir grandes flujos de migrantes. “Primero porque países de América Latina no están construidos por migrantes como sí lo es Estados Unidos", señaló, haciendo hincapié en que la situación actual podría ser insostenible si se intensifican las deportaciones de Trump.See omnystudio.com/listener for privacy information.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Incident Heart Failure Risk.

The scientific literature has shown that females demonstrate more aversion to risk-taking than males. Studies have also demonstrated that the basal lateral amygdala, or BLA, is a critical hub for processing risk and reward information. And yet further research has shown that activity in the amygdala differs between males and females, and that the expression of particular dopamine receptors called D2 receptors are greater in females than in males. The authors hypothesized that one mediating mechanism that leads to greater risk aversion in females is differential activity of dopamine in the basal lateral amygdala. Caitlin Orsini is an assistant professor in the departments of psychology and neurology at UT Austin. Hosted on Acast. See acast.com/privacy for more information.

GVOZD vibez: 1.Bonnot- Koomale 2.ShockOne - Organism Algorithm (Bensley Remix) 3.Gu:Stuff - Let's Go Back 4.Circumference - Throw Me Thats Spanner 5.Kyrist - Wreckage (InsideInfo Remix) 6.Scurrow - Melting Pot 7.Dkn - Spirits 8.Petroll - Kraken 9.Dubdron - Off The Hook 10.Phace - DIGGA 11.Nais - Love You Babe 12.Futurebound, BMotion - Slap Suey (TANTRON Remix) 13.Mean Teeth - 3 Minutes (Metanoia Remix) 14.Apashe - Lost In Mumbai (feat. Geoffroy) (Synergy Remix) 15.Paperclip - Steering Girl 16.Malstrom - Nine Breaker 17.Irontype & Blackman - Metal Ray 18.Receptor, Yush, Soham Pathak - Ambabai 19.First Person - Thoughts & Emotions 20.Kubrak - Got Your Way 21.TRCD - Break Point 22.Irontype & Frosta - Your Eyes 23.Stonx & Sindicate - Gyra 24.Teddy Killerz - NRG (feat. Inja) 25.Theezer ft. Moody Djins - Control 26.Surge - Kamikaze 27.Jack Mirror, Kove - Placebo (Fade Black Remix) 28.Muzzy - Rain Dance 29.Aphrodite - Style from the Darkside (Trippcore Remix) 30.René LaVice - Vibe Check feat. Jasmine Knight (Extended Mix) 31.Kleu, Sola - Stadium (Sola VIP) 32.Dub Elements - Bassface 33.Feed Me - One Click Headshot (Grafix Remix) 34.Solara [UK] - RAGE 35.Mage - Yolochka 36.Dr. Apollo - If You Want To Rave (Dance With Me) (Euphonique Remix) 37.ShockOne - Say Woah (DON DARKOE REMIX) 38.Ric Waves, JRACE, Albert White & LATEMOVE - Let Me Down 39.Konetix - Bust A Clip 40.Jabba, Lavance - Too Much 41.Jakes, T>I - Kamikaze 42.Bleach - Blips 43.GLXY - Rotor 44.Alibi, Yatuza - Foundation 45.Objectiv, Illament - OG Call 46.Ego Trippin, Iffy - U aint on my vibe 47.Jakes, Critical Impact - Lightning 48.Melinki, Myth - Panic Room 49.Jakes, D*Minds - The Rilla 50.Zap - Martian Bubble Tea 51.Azpect - Catalyst 52.The 4'20' Sound, Parly B - Clash 53.Jando - Brazilian Jungle 54.Serum, Need For Mirrors - Cut & Shut (Need For Mirrors Remix)

01. Bl3Ss & Camrinwatsin feat. Bbyclose - Craving 4 U (Ivy Remix) 02. Charlotte Haining - Sinner 03. B-Complex X Reebz - As The Rush Comes 04. René Lavice - Vibe Check feat. Jasmine Knight (Extended Mix) 05. Solara [Uk] - Rage 06. Madface - In The Club 07. Mage - Yolochka 08. Streetflicker - Drama 09. Karacha - Bad Day (Vip) 10. M00Set - Ya Asfour (Levia Remix) 11. Kubrak - Got Your Way 12. Gancher & Ruin & Tochnorockstar - Teriay 13. Stonx & Sindicate - Gyra 14. Gntlman - Drums & Bass 15. Trcd - The Beast (Vip Mix) 16. Despersion - Komety (Remix) 17. First Person - Thoughts & Emotions 18. Receptor & Paperclip - Long Story 19. Dysta - Spiral 20. Zombie Cats & Young Bucks - Timeless (Zombie Cats & Nemean Remix) 21. Irontype & Frosta - Your Eyes 22. Trcd - Break Point 23. Task Horizon - Astroturf 24. Nerv3 - Coded 25. Milky - Tired 26. Irontype - Bass Drop 27. Surge - Kamikaze 28. Theezer - Prime Of Life 29. Future Shock - Emotion Illusion 30. Zak Meow X Mad Hed City - Badniss Prevail 31. The 4'20' Sound, Parly B - Clash 32. Dr. Apollo - If You Want To Rave (Dance With Me) (Euphonique Remix) 33. Jack Mirror, Kove - Placebo (Fade Black Remix) 34. Hologram - Ghosts Vip feat. Degs 35. Slaine - Vert 36. Radiax - Hard To Resist 37. Aarmo & Isohel - Runaway 38. Noise Souls - Sequence V2 (Boat Sink) 39. M@Shinist - Zap Vip (Original Mix) [Basseffect] 40. Azpect - Catalyst 41. Alora - Mythology (Original Mix) 42. Bonnot - Koomale 43. The Dirtmerchant, Mc Questionmark - Water Color Dreams 44. Cptr - Test Result 45. Ńemy - 1970 46. Haze - Not The One 47. Noco, Emcd, Tripzilla - Vossy feat. Tripzilla 48. Reaktiv, Bozz - Move With Me 49. Nkz - Speed Walk 50. Unkn0Wn Dub - Run 51. Log1N, Order Up, Peas - Time For Love 52. Scurrow - Melting Pot 53. Chris Kastro - London City 54. Alibi, Yatuza - Foundation 55. Taxman - Sekkle Dub 56. Konetix - Bust A Clip 57. Dj Hazard - Nasty Place 58. Aphrodite - Style From The Darkside (Trippcore Remix) 59. Zap - Martian Bubble Tea 60. Fx909 - Gold Mine 61. Drum Dad & Bass Boy - Junky 62. Poliqpoliq - Mystical Flowers 63. Jack South - Belle Vue 64. Rodney Rolls - London Something 65. Dubsky & Magnafide - Handsome Devils (Midnite Aura Vip) 66. Clipz - Tell Them feat. Stush (Extended Mix) 67. Masson - Jungle Biz 68. Vansnatch - I'Ve Tried 69. Krugah - Tower Jam 70. Rea - On The Road (Thys Remix) 71. Catching Cairo & Mania - All Good 72. Qumulus, Warm Roller - Blind Faith 73. Capricorn 15 - Royalston 74. Bad 4 Life, Antoanesko - Blue Note (Original Mix) 75. Filthy Philp - I Need U 76. Maxxumus - Blenny 77. Mage - Into The Unknown 78. Raybak X Kvostax - Girl From The East 79. Solar Moves - Spattered 80. Тося Чайкина - Ещё (Singlep Bootleg)

Dr. Tesha Monteith discusses the Brain & Life article, “Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?” by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org.  Show reference: https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders 

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities — Hope S Rugo, MD CME information and select publications

Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics: Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00) First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04) Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11) Beyond the Guidelines Survey (35:36) Faculty Case Presentations (51:27) CME information and select publications

In this episode, we review the high-yield topic of ⁠Selective Estrogen Receptor Modulators (SERMs)⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Gynecology section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠ Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

Hey everyone,We're back with another stacked episode! This week, we've got fresh heat from Splatii, Ed Rush, ChaseR, and the powerhouse collaboration of Receptor x Yush!Then, we're diving into Demos WIPs and Promos for some killer tracks EmZee, It's Tricky, Ekwols, and O&P.As always, Ollie's here to guide you through the finest cuts of the past few weeks.TRACKLIST AND MORE INFO: https://www.stonxmusic.co.uk/stonxcast-ep115Stonx -Ghola /Ereboscygnusmusic.link/bzwpdw6Don't forget you can catch us LIVE recording Stonxcast on Twitch every Friday at 7pm (UK)